Christopher John Montague Meade

USPTO Granted Patents = 11 (Patent Applications = 3)

CIPO Patents = 1

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 5.5

ph-index = 6

Forward Citations = 143(Granted Patents)

Location History:

Bingen am Rhein, DE (2002)
Bingen, DE (2001 - 2008)
Maselheim, DE (2009 - 2010)

Company Filing History:

5 out of 149

Boehringer Ingelheim Pharma Kg

patents

5 out of 194

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

1 out of 1,537

Boehringer Ingelheim International Gmbh

patents

Years Active: 2001-2010

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7851483 - Medicaments comprising steroids and a novel anticholinergic (2010-12-14),

2. 7776315 - Pharmaceutical compositions based on anticholinergics and additional active ingredients (2010-08-17),

3. 7507745 - Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins (2009-03-24),

4. 7417051 - Medicaments comprising betamimetics and a novel anticholinergic (2008-08-26),

5. 7244742 - Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic (2007-07-17),

6. 7084153 - Medicaments comprising steroids and a novel anticholinergic (2006-08-01),

7. 6492377 - Imidazotriazolopyrimidines with adenosine-antagonistic activity (2002-12-10),

8. 6417190 - Tricyclic nitrogen heterocycles as PDE IV inhibitors (2002-07-09),

9. 6288277 - Benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments (2001-09-11),

10. 6265612 - Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect (2001-07-24),

11. 6197824 - Benzamidine derivatives and the use thereof as medicaments with LTB4-antagonistic effect (2001-03-06),

Title: Christopher John Montague Meade: A Tech Pioneer Revolutionizing Respiratory Disease Treatment

Introduction: Christopher John Montague Meade, a visionary inventor hailing from Maselheim, DE, is a true trailblazer in the realm of technology and innovation. With a total of 11 patents to his name, his unwavering commitment to creating inventions that leave a positive impact on society sets him apart as a pioneer in his field.

Latest Patents: Among his latest patents is a groundbreaking medicament comprising steroids and a novel anticholinergic. This pharmaceutical composition offers a unique blend of anticholinergics and additional active ingredients, including corticosteroids, dopamine agonists, and more. These innovations are aimed at revolutionizing the treatment of respiratory diseases.

Career Highlights: Throughout his illustrious career, Christopher John Montague Meade has made significant contributions to the field of pharmaceuticals. Notably, he has worked with renowned companies such as Boehringer Ingelheim Pharma GmbH & Co. KG, where his innovative spirit has been instrumental in driving forward cutting-edge research and development initiatives.

Collaborations: Collaborating with esteemed coworkers like Michael Paul Pieper and Michel Pairet, Christopher John Montague Meade has fostered a culture of innovation and excellence. Together, they have spearheaded projects that have the potential to shape the future of respiratory disease treatment.

Conclusion: Christopher John Montague Meade's relentless pursuit of innovation and his passion for leveraging technology to make a positive impact on society underscores his status as a true pioneer in the world of invention. His groundbreaking patents and extensive contributions to the field exemplify his unwavering dedication to advancing science for the betterment of humanity.

This text is generated by artificial intelligence and may not be accurate.